Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/215286
Clinical Impact of the Use of Ologen in Filtering Surgery Performed in Uncontrolled Glaucoma
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Introduction: To compare the efficacy and safety of trabeculectomy with a collagen matrix implant (Ologen (R)) versus trabeculectomy with mitomycin C (MMC) versus trabeculectomy with both Ologen (R) and MMC (OLO + MMC). Methods: This non-randomized study included 119 eyes of 101 patients with uncontrolled open-angle glaucoma who underwent trabeculectomy, either alone or combined with phacoemulsification. The data were initially recorded following a standard surgical protocol, using an electronic database with structured fields. The patients were divided into three groups: 44 received trabeculectomy with adjunctive MMC (MMC group), 34 received surgery with Ologen (R) (OLO group), and 41 received surgery with both Ologen (R) and MMC (OLO + MMC group). The main outcome measures were the change in intraocular pressure (IOP), change in number of medications needed, complete success rate (defined as IOP <= 20 mmHg and at least 20% IOP reduction without hypotensive medications), rate of complications, and rate of postoperative interventions. The follow-up period was 36 months. Results: IOPs significantly decreased (p = 0.01) in all groups across all study visits, decreasing from 19.8 +/- 4.6 mmHg to 12.7 +/- 4.2 mmHg in the MMC group, from 20.5 +/- 4.7 mmHg to 13.9 +/- 3.5 mmHg in the OLO group, and from 23.5 +/- 6.1 mmHg to 13.1 +/- 3.5 mmHg in the OLO + MMC group. After correcting for the baseline IOP, only the first two postoperative visits (first week and first month) showed a significantly greater IOP reduction in the OLO + MMC group. The number of hypotensive medications was significantly reduced from 3.1 +/- 0.6 to 0.56 +/- 1.1 in the MMC group, from 2.9 +/- 0.4 to 0.83 +/- 1.1 in the OLO group, and from 3.0 +/- 0.6 to 0.45 +/- 0.95 in OLO + MMC group, with no statistically significant differences among the groups (p = 0.57). The complete success rates were 63.6% in the MMC group, 67.6% in the OLO group, and 80.5% in the OLO +MMC group, with no statistically significant differences between the groups (p = 0.21). Suture release was significantly more frequent in the MMC group (86.1%) than in the OLO group (62.1%) and in the OLO + MMC group (45.9%; p = 0.02). Bleb needling, with (33.3%; p = 0.005) or without (66.7%; p = 0.0001) 5-fluorouracil injection (5-FU), was significantly more common in the MMC group. The highest complete success rate (61%) was observed in the OLO + MMC group. Conclusions: The use of Ologen (R) and mitomycin C provided similar surgical IOP reduction in glaucoma surgery compared with either MMC or Ologen (R) alone, but significantly reduced the need for postoperative interventions.
Matèries
Matèries (anglès)
Citació
Citació
NAVERO RODRÍGUEZ, José manuel, BOLDÚ ROIG, Júlia, PINILLA, Laura, VIDAL MARTÍ, María, ANTÓN, Alfonso. Clinical Impact of the Use of Ologen in Filtering Surgery Performed in Uncontrolled Glaucoma. _Journal of Clinical Medicine_. 2024. Vol. 13, núm. 15. [consulta: 20 de gener de 2026]. ISSN: 2077-0383. [Disponible a: https://hdl.handle.net/2445/215286]